Government ‘a long way off’ from meeting targets to control AMR infections Despite the government’s goal of reducing antimicrobial-resistant infections by 10% between 2018 and 2025, a National Audit Office report found that infections in England had risen by 2023 to 13% above the 2018 baseline.…
Whooping cough cases increase by 1,600% in a year, data show Data from the UK Health Security Agency show that in 2024, the total number of pertussis cases exceeded the total cases observed during the 2012 whooping cough outbreak in England.…
SIGN rejects opioids and medicinal cannabis for chronic pain in draft guidance Draft guidance on management of chronic pain included medicinal cannabis for the first time, not recommending it on the basis of limited clinical evidence and consistent evidence of adverse effects.…
Inclisiran prescribed to 7% of expected target population in three years, NHS data reveal Exclusive: The Royal College of General Practitioners and the British Medical Association maintain that caution should be taken when prescribing inclisiran since long-term trial data on the drug will not be available until 2026.…
Test your knowledge of gastrointestinal conditions This CPD and learning quiz can help you assess your knowledge of a range of issues affecting the gastric system.…
Global health partnerships are essential for tackling antimicrobial resistance International partnerships between healthcare organisations can be mutually beneficial in reaching global health targets relating to antimicrobial resistance, says Nisha Thakrar.…
Inhaler return to pharmacies part of updated NHS ‘Green plan guidance’ The updated guidance encourages trusts and other NHS organisations to renew their sustainability plans for the next three-year cycle in order to help achieve NHS net zero carbon emissions.…
The novel schizophrenia drug showing renewed potential for better outcomes A novel acetylcholine receptor drug has become the first new medicine to treat schizophrenia in decades. But even after gaining approval in the United States, experts are still conflicted on its benefits over current antipsychotic medicines.…
NICE approves gene-editing sickle cell therapy for NHS in England Exagamglogene autotemcel, also known as exa-cel, is now recommended for NHS use, reversing previous draft guidance.…
MHRA warns of pulmonary aspiration risk for GLP-1 receptor agonists during general anaesthesia or deep sedation A review has found that all available data support a risk of pulmonary aspiration from glucagon-like peptide-1 or dual glucose-dependent insulinotropic polypeptide receptor agonists, owing to their association with delayed gastric emptying.…
